ArticleBJC reports2025

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification.

Takuma Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.